What Netsensing Technology does

Netsensing Technology Sàrl is a Swiss medical-IoT company founded in 2018 and headquartered at the Microcity innovation park in Neuchâtel. Its sole commercial product is HSATPro, a Home Sleep Apnea Testing device intended for use by Health Care Professionals to aid in the diagnosis of sleep apnea in adult patients in both home and hospital settings. HSATPro records thoracic and abdominal respiration, blood oxygen saturation, heart rate, respiratory effort, and body position, then fuses these channels through a patented algorithm to compute the Apnea-Hypopnea Index in real time, in compliance with AASM guidelines, and outputs a diagnostic report for the clinician. The company positions the device as a faster, easier, and lower-cost alternative to incumbent sleep apnea detection procedures, targeting CE Class IIa (EU) and FDA Class II (US) medical-device classification.

The company's business model centers on direct (quote-based) unit sales of the HSATPro device to HCPs and clinical institutions; pricing is not publicly disclosed. To date, the company has been financed primarily through non-dilutive European and Swiss innovation funding, including an EU Horizon 2020 grant (Grant Agreement N°824920) and a SmartEEs2 grant. Revenue is not disclosed and no commercial customers are named in the source material. Distribution is limited to a corporate website and contact form; there is no evidence of e-commerce, marketplace, or reseller channels.

Operationally, Netsensing runs with 1–10 employees and relies on a Swiss and EU institutional partner network — including InnoSuisse, SmarTEEES, Microcity, the Canton of Neuchâtel, Digibcube, BCN, and an EU Seal of Excellence — for credibility, infrastructure, and ecosystem support. Recognition includes the Top 50 Swiss Startups (50 Startup 2019) listing. The company remains in a pre-commercial / regulatory-clearance phase rather than a measurable revenue phase.

Name

Netsensing Technology

Legal name

Netsensing Technology Sàrl

Website

https://netsensing.ch

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Netsensing Technology Sàrl is a Swiss medtech company that sells HSATPro, a medical-IoT Home Sleep Apnea Testing device using patented multi-sensor data fusion to compute the Apnea-Hypopnea Index in real time for healthcare professionals diagnosing adult patients.

Ownership category

akta.pro rank

Product category

Sleep Apnea Diagnostics Medical Devices

NAICS

Other Measuring and Controlling Device Manufacturing (334519), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Instruments For Meas & Testing Of Electricity & Elec Signals (3825)

akta.pro primary industry

Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA)

akta.pro secondary industries

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

Keywords

• Sleep apnea diagnostics
• Medical IoT devices
• Home sleep testing
• Physiological monitoring
• AHI monitoring systems

Headquarters

HQ city

Neuchâtel

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical device hardware sales (HSATPro): Primary expected revenue stream: sale of the HSATPro Home Sleep Apnea Testing device to Health Care Professionals and institutions for adult patient diagnosis in hospital and home settings. Pricing is not publicly disclosed.
2. Non-dilutive R&D and innovation grants: Funding received from the European Union's Horizon 2020 Research and Innovation program (Grant Agreement N°824920) and from Swiss innovation supporters (InnoSuisse, Smartees), supporting development rather than commercial sales.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Netsensing Technology designs and sells HSATPro, a Home Sleep Apnea Testing medical-IoT device for healthcare professionals that records multi-sensor physiological signals during sleep and processes them via a patented algorithm to compute the AHI in real time, producing a clinical report for sleep apnea diagnosis in adult patients in home and hospital settings. Targeted regulatory classification is CE Class IIa and FDA Class II.

Product overview

Netsensing Technology Sàrl offers a single unified product, HSATPro, a Home Sleep Apnea Testing (HSAT) medical-IoT device positioned as the company's core and only listed offering. It combines a patented multi-sensor data-fusion algorithm with on-device real-time processing to detect apnea events and compute the Apnea and Hypopnea Index (AHI) in compliance with AASM guidelines, generating a report for the diagnosing healthcare professional. There are no separately listed sub-products, modules, or branded add-ons — the product is sold as one integrated hardware-plus-software solution for home and hospital use, with CE Class IIa and FDA Class II regulatory status targeted.

Differentiator

Problem solved

Functional benefit

Brands

• HSATPro: Home Sleep Apnea Testing (HSAT) device indicated for use by Health Care Professionals to aid in the diagnosis of sleep apnea in adult patients; combines data fusion with a patented method to detect apnea.

Products and services

• HSATPro HSATPro is a Home Sleep Apnea Testing (HSAT) medical-IoT device indicated for use by healthcare professionals to aid in the diagnosis of sleep apnea in adult patients. It records patient thoracic and abdominal respirations, blood oxygen saturation, heart rate, respiratory effort, and body position, and processes them in real time via a patented data-fusion algorithm to compute the Apnea-Hypopnea Index (AHI) in compliance with AASM guidelines, producing a clinical diagnostic report for the HCP. The device is intended for both home and hospital use under HCP direction, with targeted regulatory classification of CE Class IIa and FDA Class II.

Quantifiable outcome

• Sleep apnea described as a chronic ailment affecting nearly 15% of the world population, representing a large addressable screening opportunity.
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Four partnerships are on record, tiered minor, core and flagship.

• DigibcubeminorStrategic or Co-development PartnerListed as a 'Partenaire Digibcube' on the homepage partner/sponsor section. Specific scope of the partnership is not described in the supplied source.
• SmarTEEEScoreStrategic or Co-development PartnerListed as a 'Partenaire Smartees' on the homepage. SmarTEEES (Smart Textiles & Electronics Emerging Systems) is an EU/regional innovation cluster linking textile and electronics players; membership indicates ecosystem / co-development support relevant to Netsensing's wearable HSATPro device.
• Microcity SAflagshipStrategic or Co-development PartnerMicrocity SA is the Neuchâtel-based innovation park / technology campus where Netsensing Technology Sàrl is hosted (Rue de la Pierre-à-Mazel 39, 2000 Neuchâtel). Provides physical infrastructure and proximity to the regional deep-tech ecosystem.
• Canton of NeuchâtelminorStrategic or Co-development PartnerListed as a 'Partenaire Neuchatel' on the homepage, indicating regional / cantonal support for Netsensing as a local deep-tech and medtech venture.

Scale indicators4 records

Recent moves1 record

Expansion highlights4 records

Direct peers

• Itamar Medical (ZOLL Itamar): Itamar Medical's WatchPAT is one of the most widely used single-/multi-channel home sleep apnea testing devices, sold to HCPs for adult sleep apnea diagnosis. It is the closest direct competitor to Netsensing's HSATPro in target customer, indication and regulatory class.
• Nox Medical: Nox Medical's Nox T3/T3s is a leading ambulatory sleep recording system used for HSAT and polysomnography, sold to clinicians globally. It overlaps with HSATPro on multi-channel home sleep testing and HCP-targeted distribution.
• SOMNOmedics: SOMNOmedics makes SOMNOscreen and related ambulatory sleep diagnostics sold to hospitals and sleep labs across Europe. Its product portfolio and customer base overlap directly with Netsensing's HCP-targeted HSAT use case.
• Compumedics: Compumedics provides Somté PSG and related sleep diagnostics hardware/software to clinicians worldwide. Like Netsensing, it serves HCPs diagnosing sleep apnea, though at a more established, broader scale.
• CleveMed: CleveMed's SleepScout and BioCapture are HSAT-class devices sold to clinicians for home sleep apnea testing. It directly overlaps with Netsensing on product category, regulatory class and HCP go-to-market.
• Cadwell Industries: Cadwell sells sleep diagnostics hardware and software (e.g., Easy Ambulatory PSG) used by HCPs for sleep apnea diagnosis. It is comparable to Netsensing on end customer (clinicians) and diagnostic sleep apnea indication, though broader in scope.

Emerging players

• Ectosense: Ectosense's NightOwl is a finger-based, cloud-connected HSAT device positioned as a low-cost, easy-to-use home sleep apnea test. It is a like-for-like emerging competitor targeting the same affordable, scalable screening gap Netsensing cites.
• Acurable: Acurable's AcuPebble is a small wearable sensor for home-based obstructive sleep apnea diagnosis and other respiratory conditions. It targets the same HCP channel and the same low-cost, scalable home screening proposition as Netsensing.

Broad incumbents

• ResMed: ResMed is the global leader in sleep apnea and respiratory care, with HSAT products (e.g., ApneaLink) alongside CPAP and cloud platforms. It is a broad incumbent competing for the same HCP budget Netsensing targets, with far greater commercial scale.

Regional players

• BMC Medical: BMC Medical is a Chinese-based manufacturer of sleep and respiratory care devices including HSAT and CPAP products. It is a comparable HSAT/sleep apnea vendor, primarily serving Asia-Pacific rather than the EU/US markets Netsensing is targeting.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/netsensing-technology

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Netsensing Technology